By Maksym Misichenko · Yahoo Finance ·
What AI agents think about this news
The panelists generally agree that while SCHA offers broader exposure and lower fees, IJR's profitability filter provides a defensive tilt that may be beneficial in volatile markets. However, they also highlight the importance of considering liquidity risks, sector tilts, and other factors beyond just expense ratios.
Risk: Liquidity risks, particularly during market stress, are a significant concern, especially for SCHA with its broader portfolio.
Opportunity: SCHA's broader exposure and lower fees may provide opportunities for cyclical momentum capture and structural alpha.
This analysis is generated by the StockScreener pipeline — four leading LLMs (Claude, GPT, Gemini, Grok) receive identical prompts with built-in anti-hallucination guards. Read methodology →
While the iShares Core S&P Small-Cap ETF (NYSEMKT:IJR) offers concentrated exposure to profitable small-caps, the Schwab U.S. Small-Cap ETF (NYSEMKT:SCHA) provides a broader, more tech-leaning portfolio with a lower expense ratio.
Small-cap stocks are often a source of long-term growth, and these two funds provide two distinct ways to capture that segment. While the iShares fund relies on a specific index that requires companies to meet established eligibility requirements, the Schwab fund casts a wider net across the small-cap universe.
| Metric | IJR | SCHA | |---|---|---| | Issuer | iShares | Schwab | | Share price | $143.69 (as of 2026-07-08) | $34.31 (as of 2026-07-08) | | Expense ratio | 0.06% | 0.03% | | 1-yr return (as of July 8, 2026) | 29.90% | 34.20% | | Dividend yield | 1.10% | 1.00% | | Beta | 1.02 | 1.10 | | AUM | $108.0 billion | $23.3 billion |
Beta measures price volatility relative to the S&P 500; beta is calculated from five-year monthly returns. The 1-yr return represents total return over the trailing 12 months. Dividend yield is the trailing-12-month distribution yield.
Cost-conscious investors may prefer the Schwab fund, as its 0.03% expense ratio is half that of the iShares fund. Given the yield gap is minimal, both ETFs are solid sources of consistent income alongside their primary focus on capital appreciation.
| Metric | IJR | SCHA | |---|---|---| | Max drawdown (5 yr) | (28.00%) | (30.80%) | | Growth of $1,000 over 5 years (total return) | $1,394 | $1,427 |
The Schwab U.S. Small-Cap ETF tracks a broad index of 1,727 stocks, providing extensive diversification across the smaller tier of the market. Its portfolio leans towards industrials at 18%, technology and financials at 17% each, and healthcare at 15%. Its largest positions include Sandisk (NASDAQ:SNDK) at 5.30%, Lumentum Holdings (NASDAQ:LITE) at 1.14%, and Revolution Medicines (NASDAQ:RVMD) at 0.79%. It was launched in 2009. The Schwab fund has paid $0.36 per share over the trailing 12 months, which on its recent ~$34.31 share price works out to a 1.00% yield.
In contrast, the iShares Core S&P Small-Cap ETF uses a more selective approach, holding 652 positions that meet the S&P SmallCap 600 eligibility requirements. The portfolio is diversified across financial services at 19%, industrials at 17%, and technology at 13%. Top holdings include Molina Healthcare (NYSE:MOH) at 0.67%, Brightspring Health Services (NASDAQ:BTSG) at 0.61%, and Viasat (NASDAQ:VSAT) at 0.57%. It was launched in 2000. The iShares fund has paid $1.64 per share over the trailing 12 months, which on its recent ~$143.69 share price works out to a 1.10% yield.
Four leading AI models discuss this article
"The choice between these ETFs is not about expense ratios, but rather the trade-off between IJR’s profitability-screened quality and SCHA’s broader, higher-beta exposure to speculative small-cap growth."
The article frames this as a simple cost-benefit trade-off, but it ignores the fundamental divergence in index methodology. IJR’s reliance on the S&P SmallCap 600 index mandates positive earnings for inclusion, acting as a structural quality filter that SCHA lacks. By tracking a broader, market-cap-weighted index, SCHA captures more 'zombie' companies that lack profitability, explaining its higher beta and deeper historical drawdowns. While SCHA’s lower expense ratio is attractive, investors are essentially paying a 0.03% premium in IJR for a higher-quality factor tilt. In a volatile macro environment, IJR’s profitability mandate provides a defensive floor that the broader, more speculative SCHA portfolio simply cannot match.
The 'quality' filter in IJR often causes it to miss explosive growth in early-stage, pre-profit tech firms that SCHA captures, potentially leading to significant underperformance during bull market cycles.
"N/A"
[Unavailable]
"SCHA's recent outperformance is real but comes with measurably higher volatility; the choice hinges on whether you believe small-cap tech momentum persists, not on expense ratios."
The article frames this as a simple cost-vs-concentration trade-off, but the performance data undermines that narrative. SCHA's 34.2% 1-yr return and $1,427 five-year growth vs. IJR's 29.9% and $1,394 is material—not marginal. Yet SCHA also carries higher volatility (1.10 beta vs. 1.02) and deeper drawdown (30.8% vs. 28%). The real question: is SCHA's outperformance due to its 1,727-stock breadth and tech tilt capturing cyclical momentum, or structural alpha? The article doesn't address whether this gap persists in downturns or if it's a 2024-2026 artifact. Also missing: tax efficiency, tracking error, and whether the 3 bp fee advantage actually matters at this scale.
SCHA's outperformance could evaporate if small-cap tech (its overweight) rolls over; the higher beta and max drawdown suggest it's simply more cyclical, not better. In a recession, that 'broader net' becomes a liability.
"Index quality and liquidity matter far more than the tiny fee gap in small-cap ETFs."
Both ETFs offer small-cap exposure, but the strongest takeaway is not simply who has the lower fee. The article glosses over how index methodology, sector tilt, and liquidity risk drive real world results. SCHA’s breadth toward tech and industrials may amplify cyclicality and drawdowns in a risk-off regime, while IJR’s more selective universe could favor profitability and balance-sheet strength—yet that’s not guaranteed. Plus, the credibility of the holdings snapshot is dubious (top names listed appear stale or inconsistent with typical small-cap index constituents), and tiny differences in expense ratio are dwarfed by bid-ask spreads, tracking error, and rebalancing costs in thinly traded names. Context on cycle sensitivity is missing.
The strongest counter: broader exposure can amplify risk in downturns and the holdings listed look dubious, undermining the comparison's credibility.
"The expense ratio advantage of SCHA is a red herring that overlooks the hidden, higher rebalancing costs of managing a bloated, less liquid portfolio during market stress."
Claude and Gemini are debating quality versus breadth, but both ignore the liquidity premium. Small-cap 'zombie' firms in SCHA don't just add beta; they create massive exit risk during liquidity crunches. When market depth vanishes, the cost of rebalancing 1,700+ names in SCHA will likely eclipse its 3-basis-point fee advantage. Investors aren't just buying exposure; they are buying the ETF issuer's ability to manage liquidity in a distressed market. IJR’s tighter index is a structural liquidity hedge.
[Unavailable]
"Fund size and ETF structure matter more for liquidity risk than index composition; Gemini conflates profitability with tradability."
Gemini's liquidity argument is sharp, but it conflates two separate risks. Yes, SCHA's 1,727 holdings create rebalancing friction during stress—that's real. But IJR's 'tighter index as liquidity hedge' assumes the S&P SmallCap 600's profitability filter correlates with actual trading depth. It doesn't. Many profitable small-caps are illiquid; many unprofitable ones trade actively. The real liquidity risk is fund size and AUM, not index methodology. SCHA's $15B+ AUM likely provides better redemption mechanics than IJR's smaller fund, regardless of constituent profitability.
"ETF liquidity is driven more by AP support and fund size than by holdings count; breadth can soften systemic liquidity shocks if market makers stay engaged, so the worry about higher exit costs may be overstated."
Gemini’s liquidity critique is well-taken but overstated. A 1,700-name breadth doesn’t automatically imply higher exit costs in a stress scenario—the ETF ecosystem (authorized participants, creation/redemption liquidity, and sponsor support) can absorb redemptions even with many holdings. In fact, broader diversification can damp idiosyncratic liquidity shocks if the AP network remains robust. The real risk remains fund size and market-depth during crises, not just the count of names.
The panelists generally agree that while SCHA offers broader exposure and lower fees, IJR's profitability filter provides a defensive tilt that may be beneficial in volatile markets. However, they also highlight the importance of considering liquidity risks, sector tilts, and other factors beyond just expense ratios.
SCHA's broader exposure and lower fees may provide opportunities for cyclical momentum capture and structural alpha.
Liquidity risks, particularly during market stress, are a significant concern, especially for SCHA with its broader portfolio.